Chemed Co. (NYSE:CHE) Shares Sold by Schwartz Investment Counsel Inc.

Schwartz Investment Counsel Inc. cut its stake in shares of Chemed Co. (NYSE:CHE) by 0.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 117,990 shares of the company’s stock after selling 252 shares during the quarter. Chemed makes up approximately 2.5% of Schwartz Investment Counsel Inc.’s portfolio, making the stock its 9th biggest position. Schwartz Investment Counsel Inc. owned 0.78% of Chemed worth $70,908,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Assenagon Asset Management S.A. acquired a new position in Chemed in the third quarter valued at approximately $2,301,000. Ausbil Investment Management Ltd acquired a new position in Chemed in the third quarter valued at approximately $579,000. Hennion & Walsh Asset Management Inc. acquired a new position in Chemed in the third quarter valued at approximately $293,000. International Assets Investment Management LLC acquired a new position in Chemed in the third quarter valued at approximately $437,150,000. Finally, Signaturefd LLC boosted its holdings in Chemed by 14.6% in the third quarter. Signaturefd LLC now owns 454 shares of the company’s stock valued at $273,000 after purchasing an additional 58 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Chemed

In other Chemed news, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares in the company, valued at approximately $1,991,615.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the sale, the executive vice president now owns 5,990 shares in the company, valued at $3,363,864.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director George J. Walsh III sold 200 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the sale, the director now owns 3,446 shares of the company’s stock, valued at $1,991,615.70. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,144 shares of company stock worth $5,264,839. 3.32% of the stock is owned by insiders.

Chemed Stock Up 0.7 %

Shares of CHE opened at $597.20 on Friday. The stock has a 50 day moving average price of $585.73 and a 200 day moving average price of $570.28. The company has a market capitalization of $9.04 billion, a price-to-earnings ratio of 32.14, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44. Chemed Co. has a 52-week low of $502.64 and a 52-week high of $654.62.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the company earned $4.71 earnings per share. On average, equities analysts anticipate that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is currently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.